Skip to main content

Is Enstilar Foam used to treat plaque psoriasis?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on April 9, 2025.

Official Answer by Drugs.com

Yes, Enstilar is a topical spray foam applied to the skin to treat plaque psoriasis. It contains calcipotriene, a vitamin D analog, and betamethasone dipropionate, a potent corticosteroid. Enstilar is used on the skin for up to 4 weeks in people 12 years and older.

Plaque psoriasis is a long-term skin condition often found on the elbows, knees, scalp and lower back. Psoriasis is characterized by inflamed, red lesions with a silvery white scale. The raised areas may itch, burn or bleed. The exact cause of psoriasis is not known, but symptoms can usually be well-managed with treatment.

Enstilar Foam 0.005% / 0.064% contains 50 mcg of calcipotriene and 0.643 mg of betamethasone dipropionate per gram. It is manufactured by LEO Laboratories Ltd.

How do I apply Enstilar Foam?

Apply to the skin once daily for up to 4 weeks, but if your skin clears sooner, treatment may be discontinued. Follow your healthcare provider’s instructions and read the Instructions For Use that come with Enstilar Foam.

To apply:

Do NOT:

How does Enstilar Foam work?

Although the exact mechanism is not fully known, calcipotriene, a topical vitamin D analog in Enstilar Foam, is thought to help to slow down the overproduction of skin cells commonly seen in psoriasis. Corticosteroids, like betamethasone dipropionate, help to reduce inflammation, redness, itching and pain.

Learn more: Psoriasis: Pictures, Symptoms and Drug Treatment Options

How well does Enstilar Foam work for plaque psoriasis?

Enstilar Foam has been shown to be effective using a 5-point Investigator’s Global Assessment (IGA) in short-term (4 week) studies and longer-term 52-week studies.

Studies

The effectiveness of Enstilar spray foam applied once-daily was evaluated in a clinical study with over 420 adult patients with psoriasis. It was compared to the vehicle alone (foam that contains no active medicine).

Related questions

Skin improvements

After 4 weeks of treatment, 53.3% of patients using Enstilar Foam showed a result of “clear or almost clear” skin (and a 2-grade improvement in skin symptoms) compared to 4.8% for the vehicle control group, a significant effect. In addition, more than 26% of patients had skin that was “clear or almost clear” after 2 weeks, compared to 1.9% with the vehicle only.

In another study, Enstilar Foam applied once-daily was compared to the two active ingredients alone: betamethasone in vehicle and calcipotriene in vehicle. After 4 weeks, 45% of patients using Enstilar Foam showed a result of “clear or almost clear” skin (and a 2-step improvement in skin symptoms) compared to 30.7% for the betamethasone group and 14.9% for the calcipotriene group.

Long-term data

Patients who had achieved success in 4-week studies with the use of Enstilar Foam continued in a long-term treatment study for up to 52 additional weeks. Researchers looked at long-term treatment success at over 520 people using Enstilar Foam or vehicle foam. Patients applied the foam twice weekly (but not on consecutive days) up to 52 additional weeks.

Long-term use with Enstilar Foam twice weekly was more effective than the foam vehicle by:

Common side effects with Enstilar Foam may include application site irritation, application site itching, folliculitis, changes in skin color, hypercalcemia (high calcium levels), hives, and worsening of psoriasis.

Related: Enstilar Foam side effects and warnings (in more detail)

This is not all the information you need to know about Enstilar Foam (betamethasone and calcipotriene topical) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

References

Read next

How does Ilumya work to treat psoriasis?

Ilumya works by binding selectively to interleukin-23 (IL-23) which is a naturally occurring cytokine. IL-23 plays a key role in promoting inflammation and regulating other cytokines (such as IL-17) and inflammatory substances, such as TNF-α3-7. By blocking the effects of IL-23, Ilumya helps control the release of IL-17 and TNF-α, which reduces inflammation associated with psoriasis. It also decreases how many inflammatory cells are present within psoriatic lesions, helps prevent plaque formation, and resolves tissue damage. Continue reading

Prednisone: What are 12 Things You Should Know?

Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading

Where should you not use triamcinolone acetonide cream?

You should not use topical corticosteroids like triamcinolone acetonide cream on your face, groin, or axillae (underarm, armpit) unless directed by your doctor. Using triamcinolone in these areas may lead to unwanted side effects like acne, prominent blood vessels, skin thinning (atrophy), changes in skin color or unwanted hair growth. Continue reading

See also:

Related medical questions

Drug information

Related support groups